FIELD: organic chemistry, medicine, pharmacology.
SUBSTANCE: invention proposes application of 1-[4-(5-cyanoindol)-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)-piperazine and its physiologically acceptable salts as a medicinal preparation for treatment of anxiety disturbance subtype taken among subtypes of panic disturbance coupled or not coupled with the opened space fear, the opened space fear disease, obsessive-maniacal symptomatic disorders, social phobia, post-traumatic stress disorder and/or the general anxiety disturbance. Invention proposes also the application of a pharmaceutical preparation that comprises 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)-piperazine or one of its pharmaceutically acceptable salts as an active component. Indicated application expands the assortment of medicinal agents used in psychiatry.
EFFECT: valuable medicinal properties of agent.
10 cl, 9 ex
Title |
Year |
Author |
Number |
POLYMORPHOUS FORMS OF 1-[4-(5-CYANOINDOLE-3-YL)BUTYL]-4-(2-CARBAMOYLBENOFURAN-5-YL)-PIPERAZINE HYDROCHLORIDE |
2002 |
- Bate Andreas
- Khel'Fert Bernd
- Nojenfel'D Shteffen
- Knil' Khajke
- Bartel'S Mattias
- Rudol'F Zuzanne
- Bettkher Khenning
|
RU2303598C2 |
NEW APPLICATION OF UNITED AGONISTS 5-HT AND INHIBITORS OF SEROTONIN REVERSE CAPTURE |
2001 |
- Bartoshik Gerd
- Sedman Juehn
|
RU2302243C2 |
NEW USING (R)-(-)-2-[5-(4-FLUOROPHENYL)-3-PYRIDYLMETHYLAMINOMETHYL]-CHROMAN AND ITS PHYSIOLOGICALLY ACCEPTABLE SALTS |
2001 |
- Bartoshik Gerd
- Russ German
- Zejfrid Kristof
- Veber Frank
|
RU2278663C2 |
USING COMPOUND COMBINING PROPERTY OF SEROTONIN REVERSE UPTAKE INHIBITOR AND AGONIST OF 5-HT-RECEPTOR |
2001 |
|
RU2288719C2 |
NOVEL USING 2-[5-(4-FLUOROPHENYL)-3-PYRIDYLMETHYLAMINOMETHYL]-CHROMAN AND ITS PHYSIOLOGICALLY ACCEPTABLE SALTS |
2002 |
- Bartoshik Gerd
- Russ Germann
- Zejfrid Kristof
- Veber Frank
|
RU2297833C2 |
COMPOUNDS, METHOD FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION, SELECTIVE ANTAGONISTS OF 5-HT -RECEPTOR |
2001 |
- Bettkher Khenning
- Bartoshik Gerd
- Kharting Jurgen
- Van-Amsterdam Kristof
- Zejfrid Kristof
|
RU2280034C2 |
N-(INDOLCARBONYL)PIPERAZINE DERIVATIVES, METHODS FOR PRODUCTION THE SAME, PHARMACEUTICAL COMPOSITION, AND COMPOUNDS |
2000 |
- Bettkher Khenning
- Grajner Khartmut
- Kharting Jurgen
- Bartoshik Gerd
- Zejfrid Kristof
- Van-Amsterdam Kristof
|
RU2251548C2 |
DERIVATIVES OF AMIDES AND UREA AS INHIBITORS OF REUPTAKE OF 5-HT AND LIGANDS OF 5-HT1B/1D |
1998 |
- Mattsen Liza
- Bettkher Khenning
- Van-Amsterdam Kristof
- Bartoshik Gerd
- Grajner Khartmut
- Kharting Jurgen
- Rautenberg Vil'Frid
|
RU2211216C2 |
2-4-[4-(4,5-DICHLORO-2-METHYLIMIDAZOLE-1-YL)BUTYL]-1-PIPERAZINYL-5-FLUOROPYRIMIDINE, ITS SYNTHESIS AND THERAPEUTIC USING |
1998 |
- Merse-Vidal' Ramon
- Frigola-Konstansa Khordi
|
RU2191184C2 |
PARTIAL AGONIST OF DOPAMIN D2/D3 RECEPTORS - 4-{2-[4-(2,3-DICHLOROPHENIL)-PIPERAZIN-1-YL]-ETHYL}-PYPERIDIN-1-CARBONIC ACID METHILAMIDE, METHODS (OPTIONS) OF ITS OBTAINMENT AND APPLICATION |
2018 |
- Ivashchenko Aleksandr Vasilevich
- Nikitin Aleksandr Vladimirovich
- Karapetyan Ruben Navasardovich
- Kuznetsova Anastasiya Aleksandrovna
|
RU2677268C1 |